HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intra-annual and seasonal allergic conjunctivitis treatment: comparison of two therapeutic protocols].

AbstractINTRODUCTION:
Allergic conjunctivitis is the most common form of conjunctivitis encountered in daily ophthalmological practice. Its therapy can be problematic: it must be simple, free of complications, and adaptable to everyday life.
PATIENTS AND METHODS:
We conducted a randomized prospective single-center survey on 102 patients between 4 and 80 years of age who presented moderate allergic conjunctivitis. Patients were divided into two groups, one treated in monotherapy with N-acetyl-aspartyl glutamic acid (NAAGA) over 4 weeks and the other treated with bi-therapy (NAAGA and Levocabastine during the first week and NAAGA only for the next 3 weeks), with evaluation of the sum of the scores of the cardinal signs of allergic conjunctivitis at D0, D7 and D28.
RESULTS:
The two populations were homogeneous at inclusion: the majority of the patients had a history of allergies, with a nonspecific disrupted allergy workup (IgE and eosinophils) and a higher initial score for the children included in the study. The scores decreased sharply at D7 (50% reduction) and at D28 (bordering 1) with no significant difference between the two groups. Tolerance to the treatment judged by unusual sensations upon instillation was better for the NAAGA treatment (80.8% of the cases). Clinical and functional signs disappeared without recourse to corticoids.
CONCLUSION:
In the moderate forms of seasonal and intra-annual allergic conjunctivitis, NAAGA treatment alone is sufficient. The association with Levocabastine is necessary only in cases of highly bothersome functional signs. The use of corticoids should be reserved for the serious forms.
AuthorsS Lazreg, J Colin, D Renault, D Hartani
JournalJournal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 31 Issue 10 Pg. 961-7 (Dec 2008) ISSN: 1773-0597 [Electronic] France
Vernacular TitleTraitement de la conjonctivite allergique per-annuelle et saisonnière: comparaison de deux protocoles thérapeutiques.
PMID19107071 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Allergic Agents
  • Dipeptides
  • Histamine H1 Antagonists, Non-Sedating
  • Piperidines
  • isospaglumic acid
  • levocabastine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Allergic Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Protocols
  • Conjunctivitis, Allergic (drug therapy)
  • Dipeptides (therapeutic use)
  • Female
  • Histamine H1 Antagonists, Non-Sedating (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Piperidines (therapeutic use)
  • Prospective Studies
  • Seasons
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: